| Literature DB >> 34191077 |
Yong-Hoon Kim1, Yoon Seok Jung2, Kamalakannan Radhakrishnan2, Jina Kim3, In-Kyu Lee4,5, Sung Jin Cho3,5, Don-Kyu Kim6, Steven Dooley7, Chul-Ho Lee8,9, Hueng-Sik Choi10.
Abstract
Acute liver injury results from the complex interactions of various pathological processes. The TGF-β superfamily plays a crucial role in orchestrating fibrogenic response. In contrast to TGF-β1, a role of TGF-β2 in hepatic fibrogenic response has not been fully investigated. In this study, we showed that TGF-β2 gene expression and secretion are induced in the liver of CCl4 (1 ml/kg)-treated WT mice. Studies with hepatocyte specific ERRγ knockout mice or treatment with an ERRγ-specific inverse agonist, GSK5182 (40 mg/kg), indicated that CCl4-induced hepatic TGF-β2 production is ERRγ dependent. Moreover, IL6 was found as upstream signal to induce hepatic ERRγ and TGF-β2 gene expression in CCl4-mediated acute toxicity model. Over-expression of ERRγ was sufficient to induce hepatic TGF-β2 expression, whereas ERRγ depletion markedly reduces IL6-induced TGF-β2 gene expression and secretion in vitro and in vivo. Promoter assays showed that ERRγ directly binds to an ERR response element in the TGF-β2 promoter to induce TGF-β2 transcription. Finally, GSK5182 diminished CCl4-induced fibrogenic response through inhibition of ERRγ-mediated TGF-β2 production. Taken together, these results firstly demonstrate that ERRγ can regulate the TGF-β2-mediated fibrogenic response in a mouse model of CC14-induced acute liver injury.Entities:
Keywords: CCl4; ERRγ; GSK5182; IL6; TGF-β2
Mesh:
Substances:
Year: 2021 PMID: 34191077 DOI: 10.1007/s00204-021-03112-1
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153